Literature DB >> 19825384

Anti-arthritic activity of Indian monocellate cobra (Naja kaouthia) venom on adjuvant induced arthritis.

Antony Gomes1, Sourav Bhattacharya, Mousumi Chakraborty, Pushpak Bhattacharjee, Roshnara Mishra, Aparna Gomes.   

Abstract

The Indian Monocellate Cobra venom (NKV) showed anti-arthritic activity over FCA induced arthritis in male albino rats. NKV treatment (1/20th & 1/10th MLD doses x 13 days, i.p.) showed significant restoration in paw & ankle volume, paw weight. Urinary hydroxyproline, glucosamine, serum ACP, ALP and IL-10 level were restored significantly, due to NKV treatment, as compared with arthritic rats. NKV also showed significant protection against arthritis induced oxidative damages. Thus this study confirmed the scientific validation behind ancient belief and use of snake venom in arthritis as mentioned in Ayurveda. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19825384     DOI: 10.1016/j.toxicon.2009.10.007

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  19 in total

1.  Anti-arthritic activity of ferulic acid in complete Freund's adjuvant (CFA)-induced arthritis in rats: JAK2 inhibition.

Authors:  Lijuan Zhu; Zhenshan Zhang; Nannan Xia; Weifeng Zhang; Yanlin Wei; Jiashu Huang; Zhijuan Ren; Feilong Meng; Lei Yang
Journal:  Inflammopharmacology       Date:  2019-09-27       Impact factor: 4.473

2.  Anti-inflammatory and anti-oxidant properties of Curcuma longa (turmeric) versus Zingiber officinale (ginger) rhizomes in rat adjuvant-induced arthritis.

Authors:  Gamal Ramadan; Mohammed Ali Al-Kahtani; Wael Mohamed El-Sayed
Journal:  Inflammation       Date:  2011-08       Impact factor: 4.092

3.  Therapeutic effect of umbelliferon-α-D-glucopyranosyl-(2(I)→1(II))-α-D-glucopyranoside on adjuvant-induced arthritic rats.

Authors:  Vikas Kumar; Firoz Anwar; Amita Verma; Mohd Mujeeb
Journal:  J Food Sci Technol       Date:  2014-05-11       Impact factor: 2.701

4.  A high molecular weight protein extract of Mastobranchus indicus (Mi-64) having antiarthritic activity in experimental animals.

Authors:  Mohammed Aftab Alam; Santosh Kumar Sarkar; Antony Gomes
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

Review 5.  Biological Effects of Animal Venoms on the Human Immune System.

Authors:  Zharick Avalo; María Claudia Barrera; Manuela Agudelo-Delgado; Gabriel J Tobón; Carlos A Cañas
Journal:  Toxins (Basel)       Date:  2022-05-16       Impact factor: 5.075

6.  Illustration of anti-rheumatic mechanism of rheumavedic capsule.

Authors:  Sumanth Meera; Nandeep Ramaiah; Narasimharaju Kalidindi
Journal:  Saudi Pharm J       Date:  2011-07-22       Impact factor: 4.330

7.  Anti-Cancer Effect of Moroccan Cobra Naja haje Venom and Its Fractions against Hepatocellular Carcinoma in 3D Cell Culture.

Authors:  Ayoub Lafnoune; Su-Yeon Lee; Jin-Yeong Heo; Imane Gourja; Bouchra Darkaoui; Zaineb Abdelkafi-Koubaa; Fatima Chgoury; Khadija Daoudi; Salma Chakir; Rachida Cadi; Khadija Mounaji; Najet Srairi-Abid; Naziha Marrakchi; David Shum; Haeng-Ran Seo; Naoual Oukkache
Journal:  Toxins (Basel)       Date:  2021-06-04       Impact factor: 4.546

8.  Nanoparticle-conjugated animal venom-toxins and their possible therapeutic potential.

Authors:  Archita Biswas; Aparna Gomes; Jayeeta Sengupta; Poulami Datta; Santiswarup Singha; Anjan Kr Dasgupta; Antony Gomes
Journal:  J Venom Res       Date:  2012-10-23

9.  Antinociceptive and anti-inflammatory effects of orally administrated denatured naja naja atra venom on murine rheumatoid arthritis models.

Authors:  Kou-Zhu Zhu; Yan-Li Liu; Jin-Hua Gu; Zheng-Hong Qin
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-24       Impact factor: 2.629

10.  Suppression of Inflammation and Arthritis by Orally Administrated Cardiotoxin from Naja naja atra.

Authors:  Cao-Xin Chen; Jie-Yu Chen; Jian-Qun Kou; Yin-Li Xu; Shu-Zhi Wang; Qi Zhu; Lu Yang; Zheng-Hong Qin
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-12       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.